Author

M. Cipolletti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

F. Acconcia· 2 shared S. Bartoloni· 2 shared C. Busonero· 1 shared F. Bianchi· 1 shared S. Leone· 1 shared S. Pescatori· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

F. Acconcia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer

S. Bartoloni, S. Pescatori, F. Bianchi, M. Cipolletti, F. Acconcia

This study identifies ALK and MELK inhibition as potential targets for specific breast cancer subtypes by showing their impact on ER stability and proliferation.

bioRxiv · Dec 19, 2023Cancer Biology

Real-time measurement of E2:ERα transcriptional activity in living cells.

M. Cipolletti, S. Leone, S. Bartoloni, C. Busonero, F. Acconcia

This study develops stable cell lines to monitor real-time ERα transcriptional activity in response to E2 and identifies biphasic dynamics and dose-dependent effects.

bioRxiv · Jan 11, 2020Physiology